Aetion and HealthVerity are playing to their strengths with the joint launch of new tools to support biopharmas and regulators gauging new COVID-19 treatments. The first, called the Real-Time Evidence Platform, is built on an instance of Aetion's platform and focuses on up-to-date usage, safety, and effectiveness data. The Real-Time Trend Reporting and Interactive Data Visualizer, meanwhile, looks to demonstrate COVID-19's overall impact and how patients are currently accessing health care.
Read More
Read More